Xenometrix Inc. has claimed a broad patent covering the use of several technologies to measure the expression of multiple genes in eukaryotic cells in response to chemical compounds. The approach, which includes DNA microarrays, is useful for toxicology testing.

However, while companies have been licensing the patent, the income may not be enough to keep the gene expression profile